Yifat Merbl
- Immunology top 5%
- interferon and immune responses 4
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 11
- Advanced Biosensing Techniques and Applications 7
- Glycosylation and Glycoproteins Research 4
- Angiogenesis and VEGF in Cancer 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Cell Biology top 10%
-
- Peptidase Inhibition and Analysis 5
-
- Autophagy in Disease and Therapy 5
- Co-authors
- Marc W. KirschnerIrun R. CohenFrancisco J. QuintanaMerav Zucker‐ToledanoYing HuoJennifer L. GallopTao WuAmit Tzur
- Partner nations
- IsraelUnited StatesIndia
In The Last Decade
Yifat Merbl
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Immunology 429
- Molecular Biology 958
- Radiology, Nuclear Medicine and Imaging 292
- Cell Biology 194
- Oncology 227
Countries citing papers authored by Yifat Merbl
This map shows the geographic impact of Yifat Merbl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifat Merbl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifat Merbl more than expected).
Fields of papers citing papers by Yifat Merbl
This network shows the impact of papers produced by Yifat Merbl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifat Merbl. The network helps show where Yifat Merbl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yifat Merbl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 21 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 67 | |
| 8 | 2021 | 5 | |
| 9 | 2019 | 2 | |
| 10 | 2018 | 33 | |
| 11 | 2017 | 3 | |
| 12 | 2013 | 87 | |
| 13 | 2011 | 31 | |
| 14 | 2010 | 14 | |
| 15 | 2009 | 71 | |
| 16 | 2007 | 176 | |
| 17 | 2007 | 42 | |
| 18 | 2006 | 18 | |
| 19 | 2005 | 86 | |
| 20 | 2004 | 40 |
About Yifat Merbl
Yifat Merbl is a scholar working on Molecular Biology, Modeling and Simulation and Radiology, Nuclear Medicine and Imaging, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Advanced Biosensing Techniques and Applications (7 papers), Peptidase Inhibition and Analysis (5 papers), Autophagy in Disease and Therapy (5 papers), Glycosylation and Glycoproteins Research (4 papers), interferon and immune responses (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Immunology (429 citations), Molecular Biology (958 citations) and Radiology, Nuclear Medicine and Imaging (292 citations). Yifat Merbl has collaborated with scholars based in Israel, United States and India. Frequent co-authors include Marc W. Kirschner, Irun R. Cohen, Francisco J. Quintana, Merav Zucker‐Toledano, Ying Huo, Jennifer L. Gallop, Tao Wu, Amit Tzur, Eytan Domany and Avital Eisenberg‐Lerner. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.